Global Scalp Microneedling Market Size By Type (Under 0.25 mm, 0.25mm-0.3mm), By Application (Hair Transplant, Boost Hair), By Region, And Segment Forecasts, 2023 to 2032

The Global Scalp Microneedling Market was valued at USD 455 million in 2023 and is expected to reach USD 893 million by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031. This growth is fueled by increasing awareness of hair restoration treatments, rising demand for non-invasive cosmetic procedures, and the growing influence of social media on aesthetic beauty standards. Scalp microneedling is gaining popularity as a cost-effective, minimally invasive treatment for promoting hair growth, especially in patients experiencing androgenetic alopecia and other hair loss conditions.

Drivers:

1. Growing Prevalence of Hair Loss Disorders:

Hair loss affects millions globally, with factors such as aging, stress, hormonal imbalances, and environmental conditions contributing to rising incidence rates. This has led to an increased demand for effective and affordable solutions like scalp microneedling.

2. Shift Toward Minimally Invasive Aesthetic Treatments:

Consumers are increasingly opting for less invasive cosmetic procedures with shorter recovery times. Scalp microneedling meets this demand by offering hair regrowth stimulation without the need for surgery or long downtime.

3. Rise in Dermatological Clinics and Medspas:

The global expansion of dermatology clinics and aesthetic centers is creating more accessibility to microneedling treatments, thus fueling market demand.

Restraints:

1. Limited Clinical Evidence and Standardization:

Although microneedling has shown promising results, the lack of standardized treatment protocols and long-term clinical studies can hamper its adoption among medical professionals and skeptical consumers.

2. Risk of Side Effects from Improper Use:

At-home microneedling kits, if used incorrectly, can lead to infections, skin damage, or irritation, potentially hindering consumer confidence in the treatment.

Opportunity:

1. Integration with Hair Growth Serums and PRP Therapy:

Microneedling combined with platelet-rich plasma (PRP) or active hair serums enhances treatment outcomes, opening up new avenues for product innovation and bundled treatment services.

2. Expansion in Emerging Markets:

Rising disposable incomes, increased awareness of aesthetic solutions, and growing healthcare infrastructure in regions such as Asia-Pacific and Latin America present vast growth opportunities for market players.

Market by System Type Insights:

Based on system type, the Dermaroller Devices segment accounted for the largest market share in 2023. Dermarollers are widely adopted due to their affordability and ease of use in both clinical and at-home settings. However, the Automated Microneedling Pens segment is expected to witness the fastest growth, driven by superior efficacy, precision control, and increasing usage by dermatologists.

Market by End-use Insights:

The Dermatology Clinics segment dominated the market in 2023, accounting for over 45% of global revenue. These clinics are equipped with trained professionals and medical-grade devices, ensuring better outcomes and patient trust. Meanwhile, the Home-Use segment is gaining traction due to rising e-commerce sales and consumer interest in self-care.

Market by Regional Insights:

North America led the global scalp microneedling market in 2023, attributed to high consumer awareness, strong aesthetic services industry, and early adoption of innovative technologies. Asia-Pacific is anticipated to grow at the fastest rate during the forecast period due to increasing disposable income, beauty consciousness, and rapid urbanization.

Competitive Scenario:

Key players operating in the scalp microneedling market include Dr. Pen, Dermaroller GmbH, MD Needle Pen, Bellus Medical (SkinPen), BeautyBio, Follica Inc., Eclipse Aesthetics, Dermedics, and BeautyBio GloPRO. Companies are focusing on R&D, strategic partnerships, and marketing innovations to enhance product efficacy and expand market presence.

Key Market Developments:

2023: Dermaroller GmbH introduced an advanced titanium microneedling roller specifically designed for scalp application, enhancing comfort and penetration efficiency.

2024: Follica Inc. initiated Phase III clinical trials for a microneedling-based hair follicle neogenesis system integrated with proprietary topical compounds.

2025: MD Needle Pen announced the release of its AI-assisted microneedling pen capable of adjusting needle depth and frequency in real-time based on scalp analysis.

Scope of Work – Global Scalp Microneedling Market

Report Metric Details

Market Size (2023) USD 455 million

Projected Market Size (2031) USD 893 million

CAGR (2023–2031) 8.7%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rise in non-invasive treatments, growth in hair loss cases

Opportunities Expansion in emerging markets, integration with PRP/serums

FAQs:

1) What is the current market size of the Global Scalp Microneedling Market?

The Global Scalp Microneedling Market was valued at USD 455 million in 2023.

2) What is the major growth driver of the Global Scalp Microneedling Market?

The market is primarily driven by the growing prevalence of hair loss and the rising preference for non-invasive cosmetic procedures.

3) Which is the largest region during the forecast period in the Global Scalp Microneedling Market?

North America holds the largest share of the market during the forecast period.

4) Which segment accounted for the largest market share in the Global Scalp Microneedling Market?

The Dermatology Clinics segment held the largest market share in 2023.

5) Who are the key market players in the Global Scalp Microneedling Market?

Key players include Dr. Pen, Dermaroller GmbH, MD Needle Pen, Bellus Medical, Follica Inc., and BeautyBio.

Let me know if you want this converted into a downloadable document.